Faculty

Institution

Unit

Venue

Jürgen B. Bulitta

Professor and The Perry E Foote Eminent Scholar Chair Professor

University of Florida

Affiliations

College of Pharmacy

Pharmacotherapy and Translational Research

Jürgen B. Bulitta is currently serving as a College Of Pharmacy Professor and The Perry E Foote Eminent Scholar Chair Professor at University of Florida.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jürgen B. Bulitta

University of Florida

Professor and The Perry E Foote Eminent Scholar Chair Professor

You can click a keyword to filter the displayed items

pharmacology clinical microbiology pharmacokinetics infectious diseases medicine antimicrobial resistance applied microbiology veterinary medicine antimicrobial chemotherapy infection control antimicrobial agents pharmacotherapy drug delivery respiratory medicine global health drug resistance population pharmacokinetics drug discovery medical microbiology microbial pathogenesis medical mycology clinical pharmacology cystic fibrosis antibacterial agents pharmaceutical sciences bacteriology klebsiella pneumoniae pharmaceutics healthy volunteers virology infectious disease modelling hollow-fiber infection model intensive care antimicrobial susceptibility clinical mycology diagnostic microbiology pharmaceutical research drug targeting mechanism-based modeling pseudomonas aeruginosa medicinal research clinical therapeutics clinical infection multiple inocula cystic fibrosis patients monte carlo simulation acinetobacter baumannii pharmacodynamic profile population pharmacokinetic modeling bone research controlled release drug analysis drug safety translational pharmacology pharmaceutical technology pharmaceutical biotechnology nanobiotechnology pharmaceutical nanotechnology viral replication physiologically-based pharmacokinetic modeling antibiotic resistance molecular microbiology molecular pharming lymphatic exposure polymyxin combinations b-lactamase inhibitors material chemistry nanoparticle research enzyme inhibition antimicrobial compounds microbial risk assessment treatment development treatment options therapeutic nanomaterials multidrug-resistant pseudomonas aeruginosa synergistic killing applied pharmacology translational research clinical research

Notable Scholarly Works

Notable Federal Grants

Collaborators

Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis. Clinical Infectious Diseases (2024)

John S BradleyJürgen B BulittaRachel CookPatricia A YuChelsea IwamotoElisabeth M HesseDanielle ChaneyYon YuJordan L KennedyDavid SueAdolf W KarchmerWilliam A BowerKatherine Hendricks

emerging infectious diseasesinfection controlrespiratory medicinemedicineinfectious diseasesanthrax meningitiscentral nervous systemepidemiology

Comprehensive Stability Analysis of 13 β-Lactams and β-Lactamase Inhibitors in in Vitro Media, and Novel Supplement Dosing Strategy to Mitigate Thermal Drug Degradation. Antimicrobial Agents and Chemotherapy (2024)

Jieqiang ZhouYuli QianYinzhi LangYongzhen ZhangXun TaoBartolome MoyaAlaa R. M. SayedCornelia B. LandersdorferEunjeong ShinCarolin WerkmanNicholas M. SmithTae Hwan KimMonika KumaraswamyBeom Soo ShinBrian T. TsujiRobert A. BonomoRichard E. LeeJürgen B. Bulitta

pharmacologyantimicrobial agentsmedicinedrug discoveryinfectious diseasesantimicrobial chemotherapycomprehensive stability analysispharmaceutical sciencesantimicrobial resistancepharmacotherapydrug analysisb-lactamase inhibitorsthermal drug degradation

Durlobactam in Combination With β-Lactams to Combat Mycobacterium Abscessus. Antimicrobial Agents and Chemotherapy (2024)

Eunjeong ShinKhalid M. DousaMagdalena A. TaracilaChristopher R. BethelMary NantongoDavid C. NguyenChidiebere AkusobiSebastian G. KurzMark S. PlummerCharles L. DaleySteven M. HollandEric J. RubinJürgen B. BulittaW. Henry BoomBarry N. KreiswirthRobert A. Bonomo

antimicrobial agentsinfectious diseasesantimicrobial chemotherapyantibacterial agentsantimicrobial resistance

Improved Characterization of Aminoglycoside Penetration Into Human Lung Epithelial Lining Fluid via Population Pharmacokinetics. Antimicrobial Agents and Chemotherapy (2024)

Eunjeong ShinYongzhen ZhangJieqiang ZhouYinzhi LangAlaa R. M. SayedCarolin WerkmanYuanyuan JiaoMonika KumaraswamyZackery P. BulmanBrian M. LunaJürgen B. Bulitta

pharmacologyantimicrobial agentspopulation pharmacokineticsdrug discoveryrespiratory medicineantimicrobial chemotherapyapplied microbiologydrug targetingdrug deliverypharmacotherapyclinical pharmacologydrug analysisdermatologyaminoglycoside penetrationpharmacokineticsepidemiology

Next Generation Antibiotic Combinations to Combat Pan-Drug Resistant Klebsiella Pneumoniae. Scientific Reports (2024)

Jan Naseer KaurNavaldeep SinghNicholas M. SmithJack F. KlemRaymond ChaYinzhi LangLiang ChenBarry KreiswirthPatricia N. HoldenJürgen B. BulittaBrian T. Tsuji

infection controlmedicinerespiratory medicinedrug resistanceantimicrobial resistanceantibiotic resistanceklebsiella pneumoniaepublic healthglobal healthveterinary medicineclinical microbiology

Population Pharmacokinetic Rationale for Intravenous Contezolid Acefosamil Followed by Oral Contezolid Dosage Regimens. Antimicrobial Agents and Chemotherapy (2024)

Jürgen B. BulittaEdward FangMartin E. StryjewskiWen WangGeorge J. AtieeJeffrey G. StarkBarry Hafkin

pharmacologyintravenous contezolid acefosamilrespiratory medicinehealth sciencesinfectious diseasesveterinary medicinepharmacokinetics

Population Pharmacokinetics and Humanized Dosage Regimens Matching the Peak, Area, Trough, and Range of Amikacin Plasma Concentrations in Immune-Competent Murine Bloodstream and Lung Infection Models. Antimicrobial Agents and Chemotherapy (2024)

Yuanyuan JiaoJun YanDhruvitkumar S. SutariaPeggy LuMichael VicchiarelliZeferino ReynaJuan Ruiz-DelgadoElizabeth BurkEugene MoonNirav R. ShahBrad SpellbergRobert A. BonomoGeorge L. DrusanoArnold LouieBrian M. LunaJürgen B. Bulitta

pharmacologypopulation pharmacokineticsamikacin plasma concentrationslung infection modelsveterinary medicineimmune-competent murine bloodstream

Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial. Veterinary and Comparative Oncology (2024)

Marilia TakadaKeita KitagawaYongzhen ZhangJürgen B. BulittaSteven MoiranoAbigail JonesJennifer BorgenAshley OnsagerTuddow ThaiwongDavid M. Vail

pharmacologyclinical trialspopulation pharmacokineticssafety propertiesveterinary medicine

Synergistic Effects of Inhaled Aztreonam Plus Tobramycin on Hypermutable Cystic Fibrosis Pseudomonas Aeruginosa Isolates in a Dynamic Biofilm Model Evaluated by Mechanism-Based Modelling and Whole Genome Sequencing. International Journal of Antimicrobial Agents (2024)

Siobhonne K.J. BreenMarina HarperCarla López-CausapéKate E. RogersJessica R. TaitThomas R. SmallmanYinzhi LangWee L. LeeJieqiang ZhouYongzhen ZhangJurgen B. BulittaRoger L. NationAntonio OliverJohn D. BoyceCornelia B. Landersdorfer

pharmacologybiofilmsbacteriologydynamic biofilm modelmechanism-based modellingapplied microbiologycystic fibrosisimmunologyglobal healthwhole genome sequencingmedical microbiologyclinical microbiology

2547. Targeting Penicillin-Binding Protein 2 (Pbp2) to Treat Metallo-Beta-Lactamase (Mbl)-Producing Klebsiella Pneumoniae: Mecillinam as an American Ninja Warrior. Open Forum Infectious Diseases (2023)

Jack F KlemPharm D CandidateJan Naseer KaurNicholas M SmithAl ChenPatricia N HoldenJürgen B BulittaBrian T Tsuji

pharmacologymedicinal chemistryinfection controlhealth sciencesmedicinemicrobial pathogenesisdrug discoverymolecular medicinerespiratory medicineapplied microbiologydrug targetingbacteriadiagnostic microbiologymedicinal researchklebsiella pneumoniaedrug developmentdisease transmissionclinical microbiology

1
2
3
4
5
20
10 / page

Jürgen B. Bulitta

Professor and The Perry E Foote Eminent Scholar Chair Professor

University of Florida

Affiliations

College of Pharmacy

Pharmacotherapy and Translational Research

Jürgen B. Bulitta is currently serving as a College Of Pharmacy Professor and The Perry E Foote Eminent Scholar Chair Professor at University of Florida.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jürgen B. Bulitta

University of Florida

Professor and The Perry E Foote Eminent Scholar Chair Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Central Nervous System Antimicrobial Exposure and Proposed Dosing for Anthrax Meningitis. Clinical Infectious Diseases (2024)

John S BradleyJürgen B BulittaRachel CookPatricia A YuChelsea IwamotoElisabeth M HesseDanielle ChaneyYon YuJordan L KennedyDavid SueAdolf W KarchmerWilliam A BowerKatherine Hendricks

emerging infectious diseasesinfection controlrespiratory medicinemedicineinfectious diseasesanthrax meningitiscentral nervous systemepidemiology

Durlobactam in Combination With β-Lactams to Combat Mycobacterium Abscessus. Antimicrobial Agents and Chemotherapy (2024)

antimicrobial agentsinfectious diseasesantimicrobial chemotherapyantibacterial agentsantimicrobial resistance

Improved Characterization of Aminoglycoside Penetration Into Human Lung Epithelial Lining Fluid via Population Pharmacokinetics. Antimicrobial Agents and Chemotherapy (2024)

Eunjeong ShinYongzhen ZhangJieqiang ZhouYinzhi LangAlaa R. M. SayedCarolin WerkmanYuanyuan JiaoMonika KumaraswamyZackery P. BulmanBrian M. LunaJürgen B. Bulitta

Next Generation Antibiotic Combinations to Combat Pan-Drug Resistant Klebsiella Pneumoniae. Scientific Reports (2024)

Jan Naseer KaurNavaldeep SinghNicholas M. SmithJack F. KlemRaymond ChaYinzhi LangLiang ChenBarry KreiswirthPatricia N. HoldenJürgen B. BulittaBrian T. Tsuji

infection controlmedicinerespiratory medicinedrug resistanceantimicrobial resistanceantibiotic resistanceklebsiella pneumoniaepublic healthglobal healthveterinary medicineclinical microbiology

Population Pharmacokinetic Rationale for Intravenous Contezolid Acefosamil Followed by Oral Contezolid Dosage Regimens. Antimicrobial Agents and Chemotherapy (2024)

Jürgen B. BulittaEdward FangMartin E. StryjewskiWen WangGeorge J. AtieeJeffrey G. StarkBarry Hafkin

pharmacologyintravenous contezolid acefosamilrespiratory medicinehealth sciencesinfectious diseasesveterinary medicinepharmacokinetics

pharmacologypopulation pharmacokineticsamikacin plasma concentrationslung infection modelsveterinary medicineimmune-competent murine bloodstream

Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial. Veterinary and Comparative Oncology (2024)

Marilia TakadaKeita KitagawaYongzhen ZhangJürgen B. BulittaSteven MoiranoAbigail JonesJennifer BorgenAshley OnsagerTuddow ThaiwongDavid M. Vail

pharmacologyclinical trialspopulation pharmacokineticssafety propertiesveterinary medicine

Jack F KlemPharm D CandidateJan Naseer KaurNicholas M SmithAl ChenPatricia N HoldenJürgen B BulittaBrian T Tsuji

1
2
3
4
5
20
10 / page

Similar Faculty Members

David Nix

Institution

University of Arizona

pharmacokinetics

infectious diseases

Sylvie Garneau-Tsodikova

Institution

University of Kentucky

pharmacology

medicinal chemistry

Charles Peloquin

Institution

University of Florida

tuberculosis

pharmacology

Zackery P. Bulman

Institution

University of Illinois Chicago

pharmacotherapeutic approaches

antibiotic resistance

Anthony Hickey

Institution

University of North Carolina at Chapel Hill

respiratory medicine

pharmacology

Annie Wong-Beringer

Institution

University of Southern California

staphylococcus aureus

clinical microbiology

Ming Hu

Institution

University of Houston

pharmacology

medicine

Gauri Rao

Institution

University of Southern California

antibiotic

antimicrobial agent

Angela Kashuba

Institution

University of North Carolina at Chapel Hill

antiviral therapy

infectious diseases (medical specialty)

Kelly E. Dooley

Institution

Vanderbilt University

hiv

tuberculosis

Similar Faculty Members

David Nix

Institution

University of Arizona

pharmacokinetics

infectious diseases

Sylvie Garneau-Tsodikova

Institution

University of Kentucky

pharmacology

medicinal chemistry

Charles Peloquin

Institution

University of Florida

tuberculosis

pharmacology

Zackery P. Bulman

Institution

University of Illinois Chicago

pharmacotherapeutic approaches

antibiotic resistance

Anthony Hickey

Institution

University of North Carolina at Chapel Hill

respiratory medicine

pharmacology

Annie Wong-Beringer

Institution

University of Southern California

staphylococcus aureus

clinical microbiology

Ming Hu

Institution

University of Houston

pharmacology

medicine

Gauri Rao

Institution

University of Southern California

antibiotic

antimicrobial agent

Angela Kashuba

Institution

University of North Carolina at Chapel Hill

antiviral therapy

infectious diseases (medical specialty)

Kelly E. Dooley

Institution

Vanderbilt University

hiv

tuberculosis